Primary cutaneous lymphomas, version 2.2020. Featured updates to the NCCN guidelines

Academic Article

Abstract

  • Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma (CTCL), and S├ęzary syndrome (SS) is a rare erythrodermic and leukemic subtype of CTCL characterized by significant blood involvement. Although early-stage disease can be effectively treated predominantly with skin-directed therapies, systemic therapy is often necessary for the treatment of advanced-stage disease. Systemic therapy options have evolved in recent years with the approval of novel agents such as romidepsin, brentuximab vedotin, and mogamulizumab. These NCCN Guidelines Insights discuss the diagnosis and management of MF and SS (with a focus on systemic therapy).
  • Digital Object Identifier (doi)

    Author List

  • Mehta-Shah N; Horwitz SM; Ansell S; Ai WZ; Barnes J; Barta SK; Clemens MW; Dogan A; Fisher K; Goodman AM
  • Start Page

  • 522
  • End Page

  • 536
  • Volume

  • 18
  • Issue

  • 5